View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Gemtuzumab Ozogamicin 3 / Daunorubicin 60 / Cytarabine 200, Acute Myeloid Leukemia, Induction, Leukocyte count up to 30,000/µl, Cycle 1
Protocol-ID: 2 V1.2 (Mini), GEMOZO3/DAUN60/CYTA200, AML, Ind., leukoc. up to 30,000/µl, C1Indication(s)
- Acute Myeloid Leukemia (CD33+); ICD-10 C92.0-, C92.5-, C93.0-, C92.8-, C92.6-, C92.7-, C92.9-
Links
- Gemtuzumab Ozogamicin [EMA EPAR]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 02.04.2021